Avenue Therapeutics, Inc.
ATXI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,696 | -$10,377 | -$3,603 | -$3,731 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,236 | $906 | $649 | $442 |
| Change in WC | $179 | -$290 | $408 | -$461 |
| Other Non-Cash | $1,255 | $310 | -$5,050 | $0 |
| Operating Cash Flow | -$9,026 | -$9,451 | -$7,596 | -$3,750 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$3,000 | $0 | $0 |
| Investing Cash Flow | $0 | -$3,000 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,623 | $7,525 | $11,497 | $5,044 |
| Stock Repurch. | $0 | $0 | -$1,104 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,214 | $1 | $148 | -$663 |
| Financing Cash Flow | $9,837 | $7,526 | $10,541 | $4,381 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $811 | -$4,925 | $2,945 | $631 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,783 | $6,708 | $3,763 | $3,132 |
| End Cash | $2,594 | $1,783 | $6,708 | $3,763 |
| Free Cash Flow | -$9,026 | -$12,451 | -$7,596 | -$3,750 |